Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polyrumix is a veterinary nutritional feed premix developed and marketed by Navana Pharmaceuticals for livestock. It is formulated as a multi-ingredient combination containing calcium propionate, silicon oxide (silicium oxide), gentianae radix, DL-methionine, cobalt carbonate, pyridoxine hydrochloride, and glucose. Polyrumix is indicated for the prevention of nutritional deficiencies, improvement of ruminal health and digestion, support of ruminal microbial activity, maintenance of optimum rumen pH, and prevention of bloat or tympany in ruminants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Polyrumix.